EXAS

Exact Sciences Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 4/10
  • Value↓ 1/10
Exact Sciences sales and earnings growth
EXAS Growth
Neutral
  • Revenue Y/Y↑ 17.69%
  • EPS Y/Y↑ 80.32%
  • FCF Y/Y↑ 378.60%
Exact Sciences gross and profit margin trends
EXAS Profitability
Neutral
  • Gross margin ↑ 69.70%
  • EPS margin↓ -6.40%
  • ROIC 5Y↓ -13.00%
Exact Sciences net debt vs free cash flow
EXAS Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 4.4
  • Interest coverage↓ -4.2

Exact Sciences stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Diagnostics & Research stocks ↗